Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 1176

1.

miR-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer.

Fan P, Liu L, Yin Y, Zhao Z, Zhang Y, Amponsah PS, Xiao X, Bauer N, Abukiwan A, Nwaeburu CC, Gladkich J, Gao C, Schemmer P, Gross W, Herr I.

Cancer Lett. 2016 Jan 28. pii: S0304-3835(16)30008-8. doi: 10.1016/j.canlet.2016.01.038. [Epub ahead of print]

PMID:
26828016
2.

Delivery of improved oncolytic adenoviruses by mesenchymal stromal cells for elimination of tumorigenic pancreatic cancer cells.

Kaczorowski A, Hammer K, Liu L, Villhauer S, Nwaeburu C, Fan P, Zhao Z, Gladkich J, Groß W, Nettelbeck DM, Herr I.

Oncotarget. 2016 Jan 27. doi: 10.18632/oncotarget.7031. [Epub ahead of print]

3.

A golden experience: Fifty years of experience managing the frontal sinus.

Chen PG, Wormald PJ, Payne SC, Gross WE, Gross CW.

Laryngoscope. 2015 Sep 22. doi: 10.1002/lary.25648. [Epub ahead of print]

PMID:
26393824
4.

Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort.

Schirmer JH, Wright MN, Vonthein R, Herrmann K, Nölle B, Both M, Henes FO, Arlt A, Gross WL, Schinke S, Reinhold-Keller E, Moosig F, Holle JU.

Rheumatology (Oxford). 2016 Jan;55(1):71-9. doi: 10.1093/rheumatology/kev286. Epub 2015 Aug 20.

PMID:
26297628
5.

Impact of general anesthesia on initiation and stability of VT during catheter ablation.

Nof E, Reichlin T, Enriquez AD, Ng J, Nagashima K, Tokuda M, Barbhaiya C, John RM, Michaud GF, Tedrow U, Gross W, Stevenson WG.

Heart Rhythm. 2015 Nov;12(11):2213-20. doi: 10.1016/j.hrthm.2015.06.018. Epub 2015 Jun 10.

PMID:
26072026
6.

[Future integrated health care in internal medicine: primary hypertension and polyangiitis with granulomatosis as modell diseases].

Raspe HH, Fölsch UR, Gross WL, Kirsten WD, Spies HF, Schumm-Draeger PM.

Dtsch Med Wochenschr. 2015 Jun;140(12):917-27. doi: 10.1055/s-0041-102338. Epub 2015 Jun 12. German. No abstract available.

PMID:
26069921
7.

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V, Dalhoff K, Dunogué B, Gross W, Holle J, Humbert M, Jayne D, Jennette JC, Lazor R, Mahr A, Merkel PA, Mouthon L, Sinico RA, Specks U, Vaglio A, Wechsler ME, Cordier JF, Guillevin L.

Eur J Intern Med. 2015 Sep;26(7):545-53. doi: 10.1016/j.ejim.2015.04.022. Epub 2015 May 9.

PMID:
25971154
8.

Predicting brain activation patterns associated with individual lexical concepts based on five sensory-motor attributes.

Fernandino L, Humphries CJ, Seidenberg MS, Gross WL, Conant LL, Binder JR.

Neuropsychologia. 2015 Sep;76:17-26. doi: 10.1016/j.neuropsychologia.2015.04.009. Epub 2015 Apr 8.

PMID:
25863238
9.

Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer.

Zhang Y, Liu L, Fan P, Bauer N, Gladkich J, Ryschich E, Bazhin AV, Giese NA, Strobel O, Hackert T, Hinz U, Gross W, Fortunato F, Herr I.

Oncotarget. 2015 Apr 30;6(12):9999-10015.

10.

Concept Representation Reflects Multimodal Abstraction: A Framework for Embodied Semantics.

Fernandino L, Binder JR, Desai RH, Pendl SL, Humphries CJ, Gross WL, Conant LL, Seidenberg MS.

Cereb Cortex. 2015 Mar 5. pii: bhv020. [Epub ahead of print]

PMID:
25750259
11.

What is your diagnosis? Obstructive intestinal foreign body.

Montgomerie SA, Van Metre RM, Gross WR, Britt TJ.

J Am Vet Med Assoc. 2015 Mar 1;246(5):505-6. doi: 10.2460/javma.246.5.505. No abstract available.

PMID:
25671280
12.

Editorial comment: integrated care and teamwork: the rashomon effect in cardiovascular medicine.

Gross WL.

A A Case Rep. 2014 Nov 1;3(9):116-7. doi: 10.1213/XAA.0000000000000073. No abstract available.

PMID:
25611861
13.

Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014.

Schönermarck U, Csernok E, Gross WL.

Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i46-52. doi: 10.1093/ndt/gfu398. Epub 2014 Dec 23. Review.

PMID:
25540095
14.

Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.

Madhavan B, Yue S, Galli U, Rana S, Gross W, Müller M, Giese NA, Kalthoff H, Becker T, Büchler MW, Zöller M.

Int J Cancer. 2015 Jun 1;136(11):2616-27. doi: 10.1002/ijc.29324. Epub 2014 Nov 25.

PMID:
25388097
15.

Thermophobicity of liquids: heats of transport in mixtures as pure component properties--the case of arbitrary concentration.

Hartmann S, Wittko G, Schock F, Gross W, Lindner F, Köhler W, Morozov KI.

J Chem Phys. 2014 Oct 7;141(13):134503. doi: 10.1063/1.4896776.

PMID:
25296817
16.

Analysis of Adverse Events Associated With Adult Moderate Procedural Sedation Outside the Operating Room.

Karamnov S, Sarkisian N, Grammer R, Gross WL, Urman RD.

J Patient Saf. 2014 Sep 8. [Epub ahead of print]

PMID:
25203503
17.

Sulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibition.

Appari M, Babu KR, Kaczorowski A, Gross W, Herr I.

Int J Oncol. 2014 Oct;45(4):1391-400. doi: 10.3892/ijo.2014.2539. Epub 2014 Jul 8.

18.

Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine.

Isayev O, Rausch V, Bauer N, Liu L, Fan P, Zhang Y, Gladkich J, Nwaeburu CC, Mattern J, Mollenhauer M, Rückert F, Zach S, Haberkorn U, Gross W, Schönsiegel F, Bazhin AV, Herr I.

Oncotarget. 2014 Jul 15;5(13):5177-89.

19.

Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication.

Forster T, Rausch V, Zhang Y, Isayev O, Heilmann K, Schoensiegel F, Liu L, Nessling M, Richter K, Labsch S, Nwaeburu CC, Mattern J, Gladkich J, Giese N, Werner J, Schemmer P, Gross W, Gebhard MM, Gerhauser C, Schaefer M, Herr I.

Oncotarget. 2014 Mar 30;5(6):1621-34.

20.

Enhancing Nitric Oxide Bioavailability via Exogen Nitric Oxide Synthase and L-Arginine Attenuates Ischemia-Reperfusion-Induced Microcirculatory Alterations.

Engel H, Friedrich S, Schleich C, Heyer M, Gebhardt MM, Gross W, Germann G, Reichenberger M.

Ann Plast Surg. 2014 Mar 29. [Epub ahead of print]

PMID:
24691313
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk